I agree that this site is using cookies. You can find further informations here.
X
Trivedi, Vaishakhi
27  results:
Search for persons X
?
1

Rare compound mutation of EGFR L858R and E709A identified i..:

Jha, Prerana ; Trivedi, Vaishakhi ; Shah, Minit...
Medical Reports.  6 (2024)  - p. 100100 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Association of Cutibacterium acnes with human thyroid cance:

Trivedi, Vaishakhi ; Noronha, Vanita ; Sreekanthreddy, Peddagangannagari...
Frontiers in Endocrinology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Targeted next generation sequencing (NGS) enables identific..:

Jha, Prerana ; Trivedi, Vaishakhi ; Kulkarni, Pooja Mahesh...
Medical Reports.  2 (2023)  - p. 100018 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Osimertinib for lung cancer cells harboring low-frequency E..:

Joshi, Asim ; Butle, Ashwin ; Hait, Supriya...
Translational Oncology.  22 (2022)  - p. 101461 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Molecular characterization of lung squamous cell carcinoma ..:

Joshi, Asim ; Mishra, Rohit ; Desai, Sanket...
Oncotarget.  12 (2021)  6 - p. 578-588 , 2021
Link: https://doi.org/10.18632..
 
?
6

Third-line therapy in the epidermal growth factor receptor ..:

Noronha, Vanita ; Pande, Nikhil ; Joshi, Amit...
South Asian Journal of Cancer.  9 (2020)  1 - p. 47-49 , 2020
Link: https://doi.org/10.4103/..
 
?
7

Outcome of uncommon EGFR mutation positive newly diagnosed ..:

Kate, Shruti ; Chougule, Anuradha ; Joshi, Amit...
Lung Cancer: Targets and Therapy.  10 (2019)  - p. 1-10 , 2019
Link: https://doi.org/10.2147/..
 
?
8

Phase III Non-inferiority Study Evaluating Efficacy and Saf..:

Patil, Vijay ; Noronha, Vanita ; Joshi, Amit...
EClinicalMedicine.  9 (2019)  - p. 19-25 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Thromboembolic events in patients with advanced stage non-s..:

Joshi, Amit ; Kate, Shruti ; Noronha, Vanita...
ecancermedicalscience.  12 (2018)  - p. , 2018
Link: https://doi.org/10.3332/..
 
?
10

Osimertinib in Indian patients with T790M-positive advanced..:

Noronha, Vanita ; Majumdar, Swaratika ; Joshi, Amit...
South Asian Journal of Cancer.  6 (2017)  4 - p. 143-146 , 2017
Link: https://doi.org/10.4103/..
 
?
11

ROS1 mutation non-small cell lung cancer—access to optimal ..:

Joshi, Amit ; Pande, Nikhil ; Noronha, Vanita...
ecancermedicalscience.  13 (2019)  - p. , 2019
Link: https://doi.org/10.3332/..
 
?
12

Outcome of uncommon EGFR mutation positive newly diagnosed ..:

Kate, Shruti ; Chougule, Anuradha ; Joshi, Amit...
info:eu-repo/semantics/altIdentifier/doi/10.2147/LCTT.S181406.  , 2019
Link: https://www.dovepress.co..
 
?
13

Phase III Non-inferiority Study Evaluating Efficacy and Saf..:

Patil, Vijay ; Noronha, Vanita ; Joshi, Amit...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510888/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane an..:

Pahuja, Kanika Bajaj ; Nguyen, Thong T ; Jaiswal, Bijay S...
qt1rh4b9zm.  , 2018
Link: https://escholarship.org..
 
?
15

Actionable activating oncogenic ERRB2/HER2 transmembrane an..:

Pahuja, Kanika Bajaj ; Nguyen, Thong T ; Jaiswal, Bijay S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248889/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
1-15